Percutaneous ventricular assist devices: OHTAC recommendation
Ontario Health Technology Advisory Committee (OHTAC)
Record ID 32017000346
English
Authors' recommendations:
The main reasons for the recommendations were as follows.
First, there was no moderate or high quality evidence showing a difference in clinically important outcomes between patients treated with Impella devices and intra-aortic balloon pumps in high risk percutaneous coronary intervention and in cardiogenic shock.
Second, given the price of the technology and the limited evidence of clinical benefit, Impella devices do not appear to provide good value for money.
OHTAC did acknowledge that there may be a small group of patients who would likely benefit from this intervention. However, given the current evidence, OHTAC did not believe that this group could be clearly identified for the purpose of a funding recommendation.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/evidence/reports/recommendation-hta-impella-1701-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Heart-Assist Devices
- Heart Failure
- Humans
- Shock, Cardiogenic
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.